Attorneys Squabble Over Cut Of $785M Pfizer FCA Deal
Attorneys who were fired less than halfway into a whistleblower case against a Pfizer subsidiary went to trial Monday to bicker over who should get credit for resolving the False Claims...To view the full article, register now.
Already a subscriber? Click here to view full article